Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Techno Medica Co., Ltd. (6678:JPX), powered by AI.
Techno Medica Co., Ltd. is currently trading at ¥2,001. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Techno Medica Co., Ltd. on Alpha Lenz.
Techno Medica Co., Ltd.'s P/E ratio is 13.8.
“Techno Medica Co., Ltd. trades at a P/E of 13.8 (undervalued) with modest ROE of 7.1%.”
Ask for details →Techno Medica Co., Ltd. is a Japanese company recognized for its specialized production and development of medical devices and diagnostic instruments. The primary focus of Techno Medica is on contributing to the healthcare industry by providing innovative solutions that improve diagnostic accuracy and patient care. The company is widely involved in the creation of automated blood sample processing systems and other vital diagnostic equipment about which healthcare professionals can significantly rely. Its devices and products play a crucial role in hospitals, clinics, and various healthcare settings, where they aid in essential diagnostics and patient management. The company's efforts in research and development have positioned it as a key player in the technological advancement of medical diagnostics, making it an integral part of the healthcare technology sector. Headquartered in Japan, Techno Medica's impact on the medical equipment market extends through collaborations and partnerships, enhancing global healthcare efficiency and quality.
“Techno Medica Co., Ltd. trades at a P/E of 13.8 (undervalued) with modest ROE of 7.1%.”
Ask for details →Techno Medica Co., Ltd. (ticker: 6678) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 244 employees. Market cap is $13.9B.
The current price is 2,001 with a P/E ratio of 13.79x and P/B of 0.96x.
ROE is 7.12% and operating margin is 13.13%. Annual revenue is $9.9B.